Over the past decade, molecular diagnostics have transformed how we assess cancer risks, help avoid unnecessary surgeries, and make personalized treatment decisions. In this episode, we’ll discuss the evolution of the molecular testing, review commonly used platforms, and explore how to apply the results effectively in clinical practice.
Explore a selection of recorded 2024 meeting sessions including surgical, basic science, and guideline based…
The Official Journal of: American Thyroid Association® Cigarette Smoking Drives Thyroid Eye Disease Progression via…
Emergency Room Visits for Hypoparathyroidism: Learning from California’s Long-term Data Elizabeth E. Cottrill
Early Prophylactic Thyroidectomy for Codon 918 RET Mutation MEN2B Felipe Augusto Brasileiro Vanderlei, Felipe Ferraz…
From Clinical Thyroidology® for the Public: Some patients with Graves’ disease develop thyroid eye disease,…
The Official Journal of: American Thyroid Association® Reproductive Concern, Fertility Intention, and Pregnancy Outcomes in…
Iatrogenic Thyrotoxicosis in Older Women: Is Weight-Based Dosing to Blame? Iram Hussain
ICG Angiography Guided Dissection of the Inferior Parathyroid Gland During Thyroidectomy Pablo Moreno Llorente, Arantxa…
From Clinical Thyroidology® for the Public: Papillary thyroid cancer has an excellent prognosis. Since the…
AMERICAN THYROID ASSOCIATION® , ATA® , THYROID® , CLINICAL THYROIDOLOGY® , and the distinctive circular logo are registered in the U.S. Patent and Trademark Office as trademarks of the American Thyroid Association® , Inc.© 2025 American Thyroid Association.
